Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 08, 2009
Tamiflu May Be Inneffective In Fighting Effects Of Flu
December 08, 2009Washington (SmartAboutHealth) - According to a new review, the popular Tamiflu is weak when it comes to the effect it has in preventing effects of the flu, such as the development of pneumonia.
The new review was carried out by researchers in Great Britain, and puts into question the highly-popular flu drug.
Tamiflu was the focus of this update to a review that was published back in 2006, and it looked into a total of 20 published clinical trials on the antiviral drug.
The trials that they examined all looked into the effectiveness of Tamiflu in regards to its ability to prevent, and treat the flu.
The review, was published in the British Medical Journal, and has found that the effectiveness of Tamiflu is certainly something to question.
The researchers had a hard time due to the fact that many of the clinical trials had incomplete data.
This could very well mean that the drug, which governments are spending billions on to stockpile, may not be very effective at all in terms of helping fight the flu and side effects of the flu.
The World Health Organization has stated they will not change their Tamiflu guidelines.
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16] 17
October 17, 2011 | Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide RiskWASHINGTON, June 12, 2008 Senator Chuck Grassley has asked the Food and Drug Administration to carefully scrutinize information it received from drug maker GlaxoSmithKline about the anxiety disorder drug Paxil, based on the contents of a newly available report about the drug's risk for suicide among adults. ...
September 21, 2009 | Topical cream studied for erectile dysfunctionScientists from Albert Einstein College of Medicine of Yeshiva University are working on a cream to rub on and treat erectile dysfunction (ED). The cream could prove to be safer than oral medications used to deliver nitric oxide to the cells that improves blood flow to treat ...
May 21, 2012 | Onyx Rises on Analyst View of Blood Cancer DrugNEW YORK -- Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company’s blood cancer drug candidate will reach $1 billion in annual sales by 2016. THE SPARK: Analyst Geoffrey Porges said he thinks that the ...
Related articles:
Oral treatment
The cyclic nucleotide phosphodiesterases constitute a group of enzymes that catalyse the hydrolysis of the cyclic nucleotides cyclic AMP and cyclic GMP. They exist in different molecular forms and are unevenly distributed throughout the body. One of the forms of phophodiesterase is ...Section: Erectile Dysfunction
Chronic prostatitis/chronic pelvic pain syndrome - prevalence
The annual prevalence in the general population of chronic pelvic pain syndrome is 0.5%. 38% of primary care providers, when presented with a vignette of a man with CPPS, indicate that they have never seen such a patient. However, the overall prevalence of symptoms suggestive of CP/CPPS is 6.3%. The role ...Section: Prostatitis
Chronic prostatitis/chronic pelvic pain syndrome - diagnosis
Diagnosis is through tests of semen, expressed prostatic secretion (EPS) or prostate tissue that reveal inflammation in the absence of symptoms.Section: Prostatitis